España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ventas
VTR
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$52.45
0.63
1.22%
At Close: -
$52.45
0
0.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Get Report
Watch
The dividend Ex-Date was 5 days ago
Ventas (VTR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Ventas (NYSE:VTR) Stock
Ventas Stock (NYSE: VTR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 05, 2024
Ventas Hits 52-Week High: Will the Stock Trend Higher?
Zacks
Wednesday, June 05, 2024
Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC's 'Final Trades'
Avi Kapoor
Tuesday, June 04, 2024
CNBC Halftime Report Final Trades: Pfizer, AS...
Benzinga Newsdesk
Thursday, May 30, 2024
Wells Fargo Maintains Equal-Weight on Ventas,...
Benzinga Newsdesk
Thursday, May 16, 2024
Scotiabank Maintains Sector Perform on Ventas...
Benzinga Newsdesk
Thursday, May 09, 2024
Looking Into Ventas's Recent Short Interest
Benzinga Insights
Thursday, May 02, 2024
Ventas shares are trading higher after the co...
Benzinga Newsdesk
Wednesday, May 01, 2024
Ventas Reiterates Guidance
Benzinga Newsdesk
Ventas Q1 2024 FFO $0.78 Beats $0.74 Estimate...
Benzinga Newsdesk
These 3 Real Estate Stocks With Over 4% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Avi Kapoor
Wednesday, April 10, 2024
Shares of REITs are trading lower as Treasury...
Benzinga Newsdesk
Friday, March 29, 2024
(VTR) - Analyzing Ventas's Short Interest
Benzinga Insights
Monday, March 18, 2024
Cracking The Code: Understanding Analyst Reviews For Ventas
Benzinga Insights
Evercore ISI Group Upgrades Ventas to Outperf...
Benzinga Newsdesk
Monday, March 04, 2024
Ventas Enters Into Cooperation Agreement With...
Benzinga Newsdesk
Thursday, February 29, 2024
Invest Like Bill Gates with These REITs
Shay Boloor
Monday, February 26, 2024
Key Takeaways From Ventas Analyst Ratings
Benzinga Insights
Wells Fargo Downgrades Ventas to Equal-Weight...
Benzinga Newsdesk
Wednesday, February 21, 2024
Wall Street's Most Accurate Analysts' Views On 3 Real Estate Stocks With Over 4% Dividend Yields
Avi Kapoor
Friday, February 16, 2024
Pfizer's Expansion Sparks Boom for these Healthcare REITs
Shay Boloor
Wednesday, February 14, 2024
Ventas Expects FY24 Normalized FFO Per Share ...
Benzinga Newsdesk
Ventas Q4 Normalized FFO Per Share $0.76 Beat...
Benzinga Newsdesk
Earnings Scheduled For February 14, 2024
Benzinga Insights
Tuesday, February 13, 2024
Shares of REIT stocks are trading lower amid ...
Benzinga Newsdesk
This REIT Could Skyrocket on Donald Trump's Presidential Bid
Shay Boloor
Sunday, February 04, 2024
Analyst Initiates Coverage On 10 Healthcare REITs, But Which Ones Are Buys?
Ethan Roberts
Tuesday, January 30, 2024
Deutsche Bank Initiates Coverage On Ventas wi...
Benzinga Newsdesk
Wednesday, January 17, 2024
Shares of REITs are trading lower amid a rise...
Benzinga Newsdesk
Tuesday, January 16, 2024
Forecasting The Future: 4 Analyst Projections For Ventas
Benzinga Insights
B of A Securities Upgrades Ventas to Buy, Rai...
Benzinga Newsdesk
Thursday, January 11, 2024
Ventas Confirms Issues Statement Regarding Th...
Benzinga Newsdesk
Wednesday, January 03, 2024
Mizuho Maintains Buy on Ventas, Raises Price ...
Benzinga Newsdesk
Monday, November 13, 2023
Wells Fargo Maintains Overweight on Ventas, L...
Benzinga Newsdesk
Thursday, November 09, 2023
Shares of REITs are trading lower amid a rise...
Benzinga Newsdesk
Wednesday, November 08, 2023
Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'
Lisa Levin
Tuesday, November 07, 2023
Ventas, Welltower Have New Growth in Senior Housing Portfolios: Analyst Says What's Next
Priya Nigam
Expert Ratings for Ventas
Benzinga Insights
Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
Wedbush Upgrades Ventas to Outperform, Raises...
Benzinga Newsdesk
Thursday, November 02, 2023
CORRECTION: Ventas Q3 Sales $1.15B
Benzinga Newsdesk
Ventas Sees FY23 Normalized FFO $2.92-$3.02 V...
Benzinga Newsdesk
Ventas Updates FY23 Normalized Per Share FFO ...
Benzinga Newsdesk
Ventas Q3 FFO $0.75 Down From $0.76 YoY, Sale...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Wednesday, October 11, 2023
Exane BNP Paribas Initiates Coverage On Venta...
Benzinga Newsdesk
Tuesday, October 03, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
Benzinga Insights
Wedbush Initiates Coverage On Ventas with Neu...
Benzinga Newsdesk
Friday, September 22, 2023
Analysts: Healthcare REITs Show A Dichotomy Of Performance
Ethan Roberts
BMO Capital Maintains Outperform on Ventas, L...
Benzinga Newsdesk
Wednesday, September 20, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
